Gaudium IVF & Women Health P/E Ratio
Current P/E Ratio
34.41
High Valuation
Very High - High growth expectations or significantly overvalued
Gaudium IVF & Women Health (GAUDIUMIVF) P/E ratio is 34.41 (High), EPS (TTM) ₹3.12, current price ₹124.39 on NSE — Very High - High growth expectations or significantly overvalued. Browse GAUDIUMIVF balance sheet details for revenue, profit, balance sheet and cash flow data.
Current Valuation Metrics
P/E Ratio
34.41
Current Price
₹124.39
EPS (TTM)
₹3.12
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
50.16
Sector Median
28.75
Sector Rank
#11 of 190
Sector Percentile
5.8%
Earnings Breakdown (TTM)
TTM EPS
₹3.70
Sept 2025
₹1.53
Mar 2025
₹1.07
GAUDIUMIVF P/E Ratio — Valuation Signal & Historical Context
Gaudium IVF & Women Health P/E 34.41 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see GAUDIUMIVF share price.
- Stock appears overvalued with PE of 34.41, suggesting caution for new investments
- Trading at discount to sector average PE of 50.16
GAUDIUMIVF vs Healthcare Peers — P/E Ratio Comparison
Gaudium IVF & Women Health P/E 34.41 vs Healthcare average 50.16, median 28.75 — range 0.97–869.57.
Sector Average
50.16
Sector Median
28.75
Lowest P/E
0.97
Highest P/E
869.57
Companies
190
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.69 | ₹1,161 | Low |
| Amwill Health Care | AMWILL | 6.34 | ₹65 | Low |
| Brooks Laboratories | BROOKS | 6.6 | ₹137 | Low |
| Mono Pharmacare | MONOPHARMA | 7.1 | ₹21 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |
| Medicamen Organics | MEDIORG | 7.51 | ₹32 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹66 | Low |